Guru Sonpavde: Phase I clinical trial unit update from Advent Health Central Florida Cancer Institute
Guru Sonpavde, Phase I Clinical Trials Director at Advent Health Central Florida and the Chair of Bladder Cancer Research, shared a post on LinkedIn:
“Phase I clinical trial unit (CRU) update from Advent Health Central Florida cancer Institute, Celebration/Orlando, Florida.
We celebrated at our annual holiday party after a year of progress:
1) we saw our portfolio of exciting trials expand,
2) co-authorship in major oral presentations (and soon to be major publications) of new cancer treatments, and
3) capped off our party with an astronomy session to see Jupiter and its moons-in many ways, the investigation of novel cancer treatments is an exciting journey at least a little similar to what Galileo must have felt when he first saw Jupiter and its moons through his telescope!
Thanks to our team that makes this all happen Lindley ‘’Lei’’ Mosqueda, Charmaine Garcia, Felipe Valerio, Jamayra Espada & many others.”
Dr. Guru Sonpavde is the Oncology and Phase I Clinical Trials Director at AdventHealth Central Florida and the Chair of Bladder Cancer Research. He is also a Professor of Medicine at the University of Central Florida. His primary focus is drug development, leading innovative clinical trials on novel immunotherapies and targeted therapies for genitourinary cancers, especially bladder cancer, along with prostate, kidney, penile, and testicular cancers.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023